SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricors upcoming FDA decision on deramiocel for Duchenne muscular dystrophy is the main focus, with traders weighing the amended upper-limb data and recent FDA rare-disease messaging against concerns about the prior review and unresolved efficacy questions. INOVIOs approval has added optimism as a possible regulatory read-through, while bullish speculation about launch-related hiring is widely discussed but is not confirmation of CAPR approval.

Solana (SOL) is a cryptocurrency launched in 2020. Solana has a current supply of 636,822,022.65079832 with 590,150,211.79771733 in circulation. The last known price of Solana is 94.05303263 USD and is down -1.56 over the last 24 hours. It is currently trading on 1189 active market(s) with $1,556,044,818.54 traded over the last 24 hours. More information can be found at https://solana.com.

Solana

Solana is under pressure amid a broader crypto selloff, with traders linking market jitters to the reported Binance security incident and concerns about exchange confidence. The community is split between bearish technical readings and fears of further losses, and dip buyers who are adding or staking SOL.

OFFICIAL TRUMP (TRUMP) is a cryptocurrency and operates on the Solana platform. OFFICIAL TRUMP has a current supply of 999,998,809.831273 with 281,866,746.118905 in circulation. The last known price of OFFICIAL TRUMP is 1.73532194 USD and is up 9.97 over the last 24 hours. It is currently trading on 744 active market(s) with $259,407,006.57 traded over the last 24 hours. More information can be found at https://gettrumpmemes.com/.

Trump For President

Discussion centers on the TRUMP meme coins steep decline and allegations that it was a pump-and-dump benefiting insiders. Bearish criticism dominates, though some holders still speculate about a rebound or short squeeze.

XPeng, Inc. is a global physical AI company, which engages in bringing artificial intelligence into the physical world to reshape future mobility and smart living. It developed a full-stack physical AI architecture spanning Turing AI chips, world foundation models, and integrated software and hardware applications. The firm's product portfolio includes smart EVs, robotaxis, and humanoid robots. The company's sales and services drives continuous technological innovation and fosters an open physical AI ecosystem, making life smarter, safer, and better for users worldwide. XPeng, Inc. was founded by Xiao Peng He, Heng Xia, and Tao He in 2015 and is headquartered in Guangzhou, China.

XPeng Inc - ADR

XPengs record October deliveries, led by rapid overseas growth, are driving discussion, while traders question whether rising volume will translate into stronger margins and whether the company can meet its Q4 goals. The delivery news is being weighed against a prolonged selloff and broader weakness in Chinese EV stocks.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Luckins scheduled third-quarter results are driving positioning, with bulls anticipating an earnings-related rebound and bears expecting further weakness. Traders also debate the stocks prolonged range-bound performance, speculating that buybacks or a future U.S. relisting could improve sentiment, though no relisting timeline is confirmed.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisks sharp selloff despite strong earnings and raised guidance has traders debating whether Kioxias cautious outlook signals cooling NAND pricing and AI-driven memory demand, with broader weakness in chip stocks adding pressure. Many see the drop as an overreaction given the companys fundamentals, while bears worry the memory cycle may be peaking and future growth could slow.

Cardano (ADA) is a cryptocurrency launched in 2017. Cardano has a current supply of 44,994,665,205.855202 with 36,823,860,963.224877 in circulation. The last known price of Cardano is 0.19280151 USD and is up 0.00 over the last 24 hours. It is currently trading on 1752 active market(s) with $154,401,668.14 traded over the last 24 hours. More information can be found at https://www.cardano.org.

Cardano

Cardanos volatile price action and difficulty sustaining rallies dominate the discussion, with many traders calling the weakness a sign of further downside. Others are accumulating and looking for a technical rebound or breakout, leaving sentiment sharply divided.

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

Gilead Sciences, Inc.

Gilead Sciences is trending as traders discuss its ongoing pipeline expansion, particularly in oncology and HIV, alongside speculation about potential future acquisitions and reactions to recent earnings. Investors are balancing optimism over the company's long-term commercial strategy with frustration over the stock's relatively steady performance compared to broader market gains.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

AAOI is drawing attention amid a sharp selloff alongside other AI-optics stocks, with traders pointing to broader tech weakness and concerns about AI spending, financing and possible further dilution rather than a clear company-specific trigger. Bulls call the drop an overreaction and cite continued data-center optics demand, while bears remain worried about volatility and the upcoming earnings report.

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, E-Vapor Products and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The E-Vapor Products segment contracts with third-party importers to supply all of its products and sells its e-vapor products to customers in the United States. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

Altria Group Inc.

Altrias quarterly results modestly beat expectations, lifted full-year EPS guidance and expanded its buyback, drawing attention as shares move to fresh highs. Traders are largely celebrating the run and the companys defensive dividend profile, while some question whether the rally can continue amid falling cigarette shipments and technical resistance.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$RFL Funny, wouldn’t do a capital raise at $3.90 which could have landed the company $50M at less than 50% dilution. It seems the plan might be to either go under and seize Trappsol for private profit for Howard &amp; Scott or to issue shares cheaply. Whichever we are actively being worked against.

$RFL - Rafael Holdings, Inc. - 10K - Updated Risk Factors 
 
Rafael adds a going-concern warning and financing risks for its Cyclo business. Cyclo’s Trappsol Cyclo NDA relies partly on subgroup and external-control data after Phase 3 missed its primary endpoint. Cyclo could also lose its MIT Alzheimer’s license if it misses a March 31, 2027 clinical-trial milestone and cannot obtain an extension or cure the failure. #Biotechnology #PharmaceuticalDevelopment #FinancingRisk #RegulatoryUncertainty #DrugPricingPressure 
 
🟢 Added 🟠 Removed 
 
https://d-risk.ai/RFL/10-K/2026-10-29

Compare RFL's 10-K risk-factor disclosures filed 2026-10-29. Review the dRisk summary and links to the current and previous SEC filings.

RFL 10-K Risk Factor Changes - 2026-10-29

StockTwits Web

Rafael Holdings Inc - Ordinary Shares - Class B

dRisk

StockTwits for iOS

 Funny, wouldn’t do a capital raise at $3.90 which could have landed the company $50M at less than 50% dilution. It seems the plan might be to either go under and seize Trappsol for private profit for Howard & Scott or to issue shares cheaply. Whichever we are actively being worked against.

Sanford Webb

@Biotechnicity What’s your average? You’ll hedge now?

 What’s your average? You’ll hedge now?

Jokair

@Jokair not even looking at it that way. Just going down with the flames. Getting out of the market. The time to hedge was at $3+. This looks more and more suspect every single day. Tc

 not even looking at it that way. Just going down with the flames. Getting out of the market. The time to hedge was at $3+. This looks more and more suspect every single day. Tc

@Biotechnicity I see below a $1, adds at .80-.95 for me. Happy to add there.

 I see below a $1, adds at .80-.95 for me. Happy to add there.

@Jokair I’ve pegged $.80 as my add target too.

 I’ve pegged $.80 as my add target too.

@Biotechnicity this has always been my underlying concern that they will find a way to run it down take the ip and profit off it privately - muzzletof!

 this has always been my underlying concern that they will find a way to run it down take the ip and profit off it privately - muzzletof!

@Bjorn_Slippy it would have helped for you to voice this concern earlier.

 it would have helped for you to voice this concern earlier.

@Biotechnicity exactly how would it have helped if a random poster who has likely lost a sh1t ton of money on this decided to make their worst nightmares known to other random posters  
 
That said if you have followed any of my messages the last 6 year you would have seen a few mentioning these uneasy thoughts even before the rfl merger

 exactly how would it have helped if a random poster who has likely lost a sh1t ton of money on this decided to make their worst nightmares known to other random posters  
 
That said if you have followed any of my messages the last 6 year you would have seen a few mentioning these uneasy thoughts even before the rfl merger

@Bjorn_Slippy very ill-dignified of me. Thanks for rising above an emotional rejoinder but that’s not what this is, is it? Tc slippery one

 very ill-dignified of me. Thanks for rising above an emotional rejoinder but that’s not what this is, is it? Tc slippery one